| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.6 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |